Drug intelligence / Profile preview

siRNA-XIST

Development stage
Preclinical
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intratumoral, Intravenous
01

Overview

siRNA-XIST is a small interfering RNA (siRNA) designed to silence the expression of the long non-coding RNA (lncRNA) known as X-inactive specific transcript (XIST). While XIST is fundamentally responsible for X-chromosome inactivation in female mammals, its aberrant overexpression has been implicated in the pathogenesis and progression of various human cancers, including hepatocellular carcinoma (HCC), breast cancer, and lung cancer. siRNA-XIST works by utilizing the RNA interference (RNAi) pathway, where it is loaded into the RNA-induced silencing complex (RISC) to guide the sequence-specific cleavage and degradation of XIST transcripts. In preclinical research, the knockdown of XIST via siRNA has been shown to inhibit tumor cell proliferation, migration, and invasion, and to sensitize cancer cells to chemotherapeutic agents by modulating various signaling pathways and microRNA networks.

Other names
XIST small interfering RNAsiRNA targeting X-inactive specific transcript
02

Targets

XIST (X inactive specific transcript)

Beyond the preview

Go deeper on siRNA-XIST.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on siRNA-XIST.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call